China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) will look for the acquisitions. David Hui Li, Chairman of China Biologic Products Holdings, commented, "In the third quarter, we were excited to announce the appointment of Bing Li as our new Chief Executive Officer. With Bing Li's deep industry experience and leadership, China Biologic Products Holdings is well positioned to further improve our governance and management systems as we upgrade our internal capabilities and explore strategic acquisitions to enhance both our portfolio of high growth products and our sales and marketing capabilities."